Efficacy and safety of ainuovirine versus efavirenz combination therapies with lamivudine/tenofovir disoproxil fumarate for medication of treatment-naïve HIV-1-positive adults: week 48 results of a randomized controlled phase 3 clinical trial followed by an open-label setting until week 96.

导出 LinkOut

翻译打印收藏纠错

第一作者： Bin,Su

第一单位： Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.

作者： Bin,Su ^[1] ; Guiju,Gao ^[2] ; Min,Wang ^[3] ; Yanqiu,Lu ^[4] ; Linghua,Li ^[5] ; Chen,Chen ^[6] ; Yuanyuan,Chen ^[7] ; Chuan,Song ^[2] ; Fengting,Yu ^[2] ; Ying,Li ^[3] ; Yixin,Liu ^[3] ; Yang,Luo ^[4] ; Haolan,He ^[5] ; Cong,Cheng ^[6] ; Lixia,Xu ^[7] ; Tong,Zhang ^[1] ; Lijun,Sun ^[1] ; An,Liu ^[1] ; Wei,Xia ^[1] ; Yuanyuan,Qin ^[1] ; Qingxia,Zhao ^[4] ; Hongxia,Wei ^[7] ; Weiping,Cai ^[6] ; Yaokai,Chen ^[5] ; Fujie,Zhang ^[4] ; Hao,Wu ^[2]

作者单位： Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China. ^[1] Clinical and Research Center for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China. ^[2] Institute of HIV/AIDS, The First Hospital of Changsha, Changsha, Hunan, 410005, China. ^[3] Department of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing, 400036, China. ^[4] Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, 510060, China. ^[5] Department of Infectious Disease, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, 210003, China. ^[6] Department of Infectious Diseases, Infectious Disease Hospital of Henan Province, Zhengzhou, Henan, 450015, China. ^[7]

关键词 Ainuovirine Efficacy HIV NNRTI Non-inferiority Phase 3 clinical trial Safety

DOI 10.1016/j.lanwpc.2023.100769

PMID 37547039

发布时间 2023-08-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

The Lancet regional health. Western Pacific

2023年36卷

100769页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Efficacy and safety of ainuovirine versus efavirenz combination therapies with lamivudine/tenofovir disoproxil fumarate for medication of treatment-naïve HIV-1-positive adults: week 48 results of a randomized controlled phase 3 clinical trial followed by an open-label setting until week 96.

The Lancet regional health. Western Pacific

相似文献

The Lancet regional health. Western Pacific

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Efficacy and safety of ainuovirine versus efavirenz combination therapies with lamivudine/tenofovir disoproxil fumarate for medication of treatment-naïve HIV-1-positive adults: week 48 results of a randomized controlled phase 3 clinical trial followed by an open-label setting until week 96.

The Lancet regional health. Western Pacific

相似文献

The Lancet regional health. Western Pacific

相关期刊

检索历史清除